⚠️ Fraud Alert: Beware of Forged Documents — It has come to our notice that unauthorized individuals are using fake Plexus letterheads and forged signatures to solicit money. We have reported the matter to the authorities and are pursuing legal action. If you receive any suspicious letter, message, or call claiming to be from Plexus, please do not engage. To verify, contact us at 📞 9355533404 | 📧 info@plexusnc.com — Please stay alert and help us spread the word.
⚠️ Fraud Alert: Beware of Forged Documents — It has come to our notice that unauthorized individuals are using fake Plexus letterheads and forged signatures to solicit money. We have reported the matter to the authorities and are pursuing legal action. If you receive any suspicious letter, message, or call claiming to be from Plexus, please do not engage. To verify, contact us at 📞 9355533404 | 📧 info@plexusnc.com — Please stay alert and help us spread the word.

MND Facts: Common Myths and What the Evidence Shows

Looking for reliable MND facts? Motor neuron disease (MND), also written as motor neurone disease, is not widely understood. Myths about who it affects, what causes it and whether anything can be done are common. Amyotrophic lateral sclerosis (ALS) is the most common type of MND, and the two names are often used interchangeably. This guide addresses such common misconceptions and explores what the evidence shows. 

Read on to understand key facts about MND.

Key MND Facts at a Glance

MND describes a group of neurological conditions that damage motor neurons, the nerve cells controlling voluntary muscle movement. ALS is the most common form. It is uncommon and is diagnosed more often in men, usually in middle or later adulthood. Around 5–10% of cases are familial, while most occur without a known family history. There is currently no cure, but multidisciplinary care can help manage symptoms and support quality of life. Clinical features of ALS include progressive weakness and other changes in motor function.

Facts About ALS

ALS stands for amyotrophic lateral sclerosis. It affects upper and lower motor neurons in the brain and spinal cord. It is also known as Lou Gehrig’s disease, after the American baseball player diagnosed in 1939. The term MND is commonly used in the UK, while ALS is more familiar in the United States. 

The ALS Ice Bucket Challenge raised awareness and funding for research. Genetic discoveries, including NEK1 variants, have advanced understanding of the condition. ALS can also overlap with frontotemporal dementia, affecting thinking, behaviour or language. NEK1 gene variants are among the genetic findings associated with ALS susceptibility.

Myth: MND Is a Muscle Disease

Fact: MND is a neurological condition, not a disease that begins in the muscles. It damages motor neurons in the brain and spinal cord, disrupting signals that control movement. As muscles receive fewer signals, they become weak and may waste away. Muscle symptoms are consequences of nerve-cell damage. This distinction is central to understanding facts about MND.

Myth: MND Only Affects Older People

Fact: MND can affect adults at different ages. It is diagnosed more often in middle and later adulthood, but younger adults can develop it too. Young-onset MND is less common, not impossible. Age alone cannot confirm or rule out the condition. Persistent or progressive symptoms need assessment by a medical professional.

Myth: MND Is Always Inherited

Fact: Most people diagnosed with ALS have no known family history. These cases are often described as sporadic MND. Around 5–10% are familial, involving inherited genetic factors. Genes such as C9orf72 and SOD1 are associated with some forms. Genetic changes may also be present without an obvious family history. A neurologist or genetic counsellor can discuss whether testing is appropriate. Genetic factors in ALS help explain why family history does not tell the whole story.

Myth: MND Is Caused by Lyme Disease or Another Infection

Fact: There is no established evidence that Lyme disease causes ALS. Some infections can produce symptoms that overlap with neurological conditions, so doctors may investigate alternative explanations during diagnosis. MND is not contagious and cannot be caught through contact with someone who has it. Lyme disease testing has not established an infectious cause of ALS.

Myth: Head Injuries or Sport Directly Cause MND

Fact: Research has explored possible associations between head injuries, contact sports and MND. However, an association does not prove that an injury or sport directly causes the condition. Findings are mixed, and further research is needed. Head injury associations have been investigated, but causation remains unproven. People should not assume that ordinary physical activity causes MND; activity should be adapted to individual ability and clinical advice.

Myth: MND Affects Everyone in the Same Way

Fact: Symptoms and progression vary. In limb-onset MND, weakness may first affect a hand, arm, leg or foot. In bulbar-onset MND, speech or swallowing difficulties may appear first. The rate of change also differs between individuals. Care needs to be reviewed over time rather than assumed from another person’s experience. These variations are important MND facts for patients and families.

Myth: MND Only Affects Movement

Fact: MND can affect more than walking or limb movement. Some people develop difficulties with speech, swallowing or breathing. Cognitive and behavioural changes can also occur, and a smaller proportion develop frontotemporal dementia. Pseudobulbar affect may cause involuntary laughing or crying. Anxiety and low mood may also need attention. Cognitive and behavioural changes are recognised within the ALS-frontotemporal spectrum.

Myth: MND Is Painless

Fact: Sensation is often relatively preserved, but MND is not always painless. Muscle cramps, stiffness and spasticity can cause discomfort. Weakness, reduced mobility, joint strain and difficulty maintaining posture may also contribute to pain. A healthcare professional can assess the cause and discuss suitable pain-management and comfort measures. Pain in ALS is an important aspect of symptom care.

Myth: Nothing Can Be Done for MND

Fact: There is currently no cure, but care can address symptoms and changing needs. A multidisciplinary team may include neurologists, physiotherapists, occupational therapists, speech and language therapists, dietitians and respiratory professionals. Support may include mobility strategies, communication aids, nutrition and breathing assessments, and emotional support. Early assessment helps people and families plan care and address changing needs. Multidisciplinary MND care supports coordinated assessment and ongoing management.

Myth: There Is No Progress in MND Research

Fact: Research continues into disease mechanisms, genetics, biomarkers and potential treatments. Scientists use patient-derived cell models, clinical trials and research registries to investigate possible approaches. Discoveries involving genes such as NEK1 have expanded understanding of ALS, but a genetic discovery does not automatically lead to a treatment. These ALS facts help distinguish scientific progress from proven clinical benefit.

Finding Reliable Information About MND

Look for evidence-based information from recognised MND associations, government health services, peer-reviewed research and specialist clinical teams. Check publication dates and whether information applies to a particular MND subtype or research stage. Ask a neurologist what a finding means for your diagnosis, which treatments are established and whether a clinical trial may be suitable. Reliable MND facts support informed decisions; they do not replace individual medical advice.

How Plexus Can Help

At Plexus, care for MND starts with a doctor-led assessment of how the condition is affecting walking, hand use, speech, swallowing and breathing.

The plan that follows is built around what matters most, and may include:

  • Physiotherapy
  • Occupational therapy
  • Speech and swallowing therapy
  • Mental health therapy for the person and their family 
  • Cell Therapy for patients found eligible after assessment 

Rehabilitation has not been shown to change the course of MND, but it can support function, comfort and participation in daily life. Plexus has centres in Bangalore and Hyderabad. The plan is reviewed regularly and adjusted as needs change. Individual outcomes vary.

If you would like to talk through what support might help, contact Plexus to enquire.

FAQs

What are the key facts about MND?

MND affects motor neurons and can cause progressive muscle weakness. Symptoms and progression vary. There is no cure, but coordinated care can help manage symptoms. 

Is MND the same as ALS?

ALS is the most common type of MND. The terms are sometimes used interchangeably, although MND can refer to a broader group of conditions.

Is MND a muscle disease or a nerve disease?

MND is a nerve disease. It damages motor neurons, the nerve cells that carry movement signals from the brain and spinal cord to muscles.

Is MND hereditary?

Most cases have no known family history and are described as sporadic MND. A smaller proportion are familial and involve inherited genetic factors.

Can young people get MND?

Yes. Although MND is more common in middle and later adulthood, young-onset MND can occur. Age of onset varies, so symptoms need medical assessment.

Can Lyme disease cause ALS?

Current evidence does not establish Lyme disease as a cause of ALS. Some symptoms may overlap, so a clinician may investigate other possible diagnoses.

Is MND painful?

Some people experience cramps, stiffness, spasticity or pain related to weakness and reduced mobility. A healthcare professional can assess symptoms and discuss pain management.

Is MND contagious?

No. MND is not contagious and cannot be caught through physical contact, sharing food or spending time with someone who has the condition.

Sources

  1. Feldman, E. L., Goutman, S. A., Petri, S., Mazzini, L., Savelieff, M. G., Shaw, P. J., & Sobue, G. (2022). Amyotrophic lateral sclerosis. The Lancet, 400(10360), 1363–1380. https://doi.org/10.1016/S0140-6736(22)01272-7
  2. Hardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017). Amyotrophic lateral sclerosis. Nature Reviews Disease Primers, 17071. https://doi.org/10.1038/nrdp.2017.71
  3. Kenna, K. P., Van Doormaal, P. T. C., Dekker, A. M., Ticozzi, N., Kenna, B. J., Diekstra, F. P., Van Rheenen, W., Van Eijk, K. R., Jones, A. R., Keagle, P., Shatunov, A., Sproviero, W., Smith, B. N., Van Es, M. A., Topp, S. D., Kenna, A., Miller, J. W., Fallini, C., Tiloca, C., & Landers, J. E. (2016). NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nature Genetics, 48(9), 1037–1042. https://doi.org/10.1038/ng.3626
  4. Qureshi, M., Bedlack, R. S., & Cudkowicz, M. E. (2009). Lyme disease serology in amyotrophic lateral sclerosis. Muscle & Nerve, 40(4), 626–628. https://doi.org/10.1002/mus.21438
  5. Watanabe, Y., & Watanabe, T. (2017). Meta-analytic evaluation of the association between head injury and risk of amyotrophic lateral sclerosis. European Journal of Epidemiology, 32(10), 867–879. https://doi.org/10.1007/s10654-017-0327-y
  6. Strong, M. J., Abrahams, S., Goldstein, L. H., Woolley, S., McLaughlin, P., Snowden, J., Mioshi, E., Roberts-South, A., Benatar, M., Hortobágyi, T., Rosenfeld, J., Silani, V., Ince, P. G., & Turner, M. R. (2017). Amyotrophic lateral sclerosis–frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(3–4), 153–174. https://doi.org/10.1080/21678421.2016.1267768
  7. Chiò, A., Mora, G., & Lauria, G. (2017). Pain in amyotrophic lateral sclerosis. The Lancet Neurology, 16(2), 144–157. https://doi.org/10.1016/S1474-4422(16)30358-1
  8. National Institute for Health and Care Excellence. (2016). Motor neurone disease: Assessment and management (NICE guideline NG42). https://www.nice.org.uk/guidance/ng42

Educational disclaimer: For educational purposes only, not medical advice. Treatment decisions require professional consultation.

Medically Reviewed By

Dr. Na’eem Sadiq

Medical Director of Plexus

Medically reviewed: November 16, 2026

Dr. Na’eem Sadiq is a neurologist and neuropsychiatrist with over 35 years of clinical experience in treating complex neurological disorders. He founded Plexus in 2011 with a mission to enhance the quality of life for people living with neurological conditions. His areas of expertise include Neurology, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Migraine, Demyelinating Polyneuropathy and Cell Therapy.

WhatsApp chat
Book a Free Consultation
Translate »

Need help deciding the next step?

Share your details and our care team will call you back.

Now available: 0 down payment treatment financing with Bajaj Finance.

    By clicking 'Submit', you agree to Terms of Use

    Before you go

    Many families start with a free medical review. No commitment.

    Now available: 0 down payment treatment financing with Bajaj Finance.

      By clicking 'Submit', you agree to Terms of Use